Navigation Links
Cardium Announces Agreement With UK-Based Angel Biomedical For Excellagen Supply And Planned European Market Expansion
Date:5/15/2012

European and other markets," stated Christopher J. Reinhard, Chairman and CEO of Cardium Therapeutics.

"The team at Angel is excited by this new partnership to provide Cardium's formulated high molecular weight collagen.  We look forward to the commercial manufacture of Cardium's Excellagen advanced wound care product and to facilitate its CE marking to assist Cardium expand its global distribution opportunities," stated Dr. Stewart White, Acting Chief Executive Officer of Angel Biotechnology.

About Excellagen

Excellagen is an FDA-cleared highly-refined fibrillar collagen-based topical gel (2.6%) designed to support favorable wound care management.  Excellagen's unique high molecular weight sterile collagen formulation is topically applied through easy-to-control, pre-filled, single use syringes. Excellagen is intended for physician use following surgical debridement procedures, and is engineered to support a favorable wound healing environment for non-healing lower extremity ulcers in diabetic patients.  Excellagen's viscosity-optimized biocompatible gel formulation requires application at only one or two week intervals. It is recommended that Excellagen be applied following surgical debridement in the presence of blood cells and platelets, which are involved with the release of endogenous growth factors.

Cardium's market research indicates that physicians seek easy-to-use products to reduce preparation time and facilitate product application - and Excellagen's unique, ready-to-use syringe-based collagen gel requires no thawing or mixing.  Because of its specialized formulation, only a thin layer needs to be applied over the wound area, and one syringe containing 0.5 cc of Excellagen covers wounds up to 5cm2 in size using the supplied 24-gauge sterile, single-use flexible applicator tip.  To learn more about new Excellagen and for product ordering information, please visit

SOURCE Cardium Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Cardium and Tissue Repair Companys Excellarate Candidate for Healing Diabetic Wounds Gains Media Focus in Multiple Regions Across U.S.
2. Cardiums Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack
3. Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities
4. Cardium Reports on Second Quarter 2008 Highlights and Financial Results
5. Cardiums InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology
6. Cardium Reports on Applicability of Corgentin to Stem Cell Therapies: Independent Studies Indicate that Ad5IGF-1 Potentiates Stem Cells to Improve Cardiac Function After Heart Attack
7. Cardium Announces Completion of Patient Recruitment in Phase 2b Clinical Trial of Excellarate(TM) for the Potential Treatment of Diabetic Foot Ulcers
8. Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study
9. Cardium Reports Non-Healing Wounds Continue to Challenge Patients and Healthcare Providers
10. Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development
11. Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... , October 1, 2014 ... Next Generation Sequencing (NGS) data analysis, today launches a ... cystic fibrosis analysis in a single NGS experiment. The ... all types of variants in a single NGS experiment ... it has not been possible to simultaneously analyse all ...
(Date:9/30/2014)... MARIETTA, Ga. , Sept. 30, 2014 ... leading regenerative medicine company utilizing human amniotic tissue and ... therapies for the Wound Care, Surgical, Orthopedic, Spinal, Sports ... Dr. Tom Koob , Ph.D., Chief Scientific Officer, ... Mesa. Dr. Koob will present on Tuesday, October 7, ...
(Date:9/30/2014)... NEW YORK , Sept. 30, 2014 /PRNewswire/ ... - 2014 Summary Global Markets Direct,s, ... 2014, provides an overview of the Aileron Therapeutics, ... report provides comprehensive information on the current therapeutic ... comparative analysis at various stages, therapeutics assessment by ...
Breaking Medicine Technology:Sophia Genetics Launches Full CFTR Analysis in Single Clinical Grade NGS Experiment 2MiMedx to Present at the Stem Cell Meeting on the Mesa 2Aileron Therapeutics, Inc. - Product Pipeline Review - 2014 2Aileron Therapeutics, Inc. - Product Pipeline Review - 2014 3
... At the 10th Asian Forum on Corporate Responsibility ... and its philanthropic foundation the Abbott Fund were honored ... advancing science education in the region.  Abbott Science Education ... innovative events designed to spark an interest in life-long ...
... Mass. and TORONTO, Oct. 24, 2011 Generex Biotechnology ... the Company is planning an investor update conference call ... to provide investors with an update on (i) the ... previously announced spinout of its wholly-owned immunotherapeutics subsidiary, Antigen ...
Cached Medicine Technology:Abbott Honored With Asian CSR Award for Leadership in Science Education 2Abbott Honored With Asian CSR Award for Leadership in Science Education 3Generex Announces Investor Update Conference Call Planned for Late November 2Generex Announces Investor Update Conference Call Planned for Late November 3
(Date:10/2/2014)... By Dennis Thompson ... -- A newborn,s risk of developing celiac disease isn,t reduced ... found in wheat called gluten to an infant,s diet help ... a pair of new studies in the Oct. 2 ... put to rest hopes that a child could avoid celiac ...
(Date:10/2/2014)... The University of Nottingham could lead to the development ... drug resulting from the research, published in the journal ... to sufferers of chronic pain conditions such as traumatic ... available. , The work, led by Dr Lucy Donaldson ... with David Bates, Professor of Oncology in the University,s ...
(Date:10/1/2014)... the Journal of the American Medical Association ... moderate or severe chronic knee pain, acupuncture did not ... Melbourne randomly assigned 282 patients (50 years or older) ... or pretend laser treatment. , Treatments were delivered ... laser and sham (inactive) laser acupuncture. , Researcher Professor ...
(Date:10/1/2014)... a policy focus on expanding access to care ... continues to have significant dental disease. In this ... American Dental Association , researchers from Tufts University ... Dental Medicine report on the first large-scale survey ... by caregivers to adults with developmental disabilities. The ...
(Date:10/1/2014)... Insuranceragents.info has released a new blog post explaining how ... family members. , Life insurance plans provide important financial ... should always carry a life insurance policy as their ... the family. , Clients can choose from several ... coverage or from a permanent policy. No medical exam ...
Breaking Medicine News(10 mins):Health News:Infant's Early Diet Doesn't Change Celiac Disease Risk, Study Finds 2Health News:Infant's Early Diet Doesn't Change Celiac Disease Risk, Study Finds 3Health News:Medical discovery first step on path to new painkillers 2Health News:Study finds acupuncture does not improve chronic knee pain 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 3Health News:Life Insurance for Families - Clients Can Compare Affordable Rates Online! 2
... Doctor Confirms Fall Should Not Pose Setback and Expects the 89-Year-Old ... Evangelist ... Graham has,returned to his mountain home in Montreat, N.C. upon his ... stay.,He was admitted for observation after he tripped over one of ...
... 6 likely to develop some form of disease by ... 10 (HealthDay News) -- Liver transplant patients have a ... researchers in Finland. , In a new study ... , researchers investigated the cancer risk pattern in 540 ...
... RICHMOND, Va., Oct. 10 Do you think that ... town? Attend the October,17 open house at the Virginia ... how instructors there empower the blind and,visually impaired to ... center., The center, located at 401 Azalea Avenue, ...
... CITY, Utah, Oct. 10 NuView Life Sciences ... Life Sciences Inc.,(Trace), including operations of the linear ... Trace facility produces,Copper-64, Copper- 67, Indium-111, Iodine-123 and ... Crowe, NuView Chairman and,CEO, stated that "We are ...
... , , FRIDAY, Oct. 10 (HealthDay News) -- In a group ... with a higher death rate, according to a new study. ... Journal of General Internal Medicine , researchers from the ... 75.6 years) who had diabetes and were enrolled in a ...
... scientists have identified a protein that plays matchmaker between ... B cells, enabling them to interact in a way ... infection. Their finding may also explain why some ... from making this proteincalled SAPsuffer from lethal infections with ...
Cached Medicine News:Health News:Billy Graham Returns Home Following Hospital Observation 2Health News:Liver Transplant Patients at Higher Cancer Risk 2Health News:Virginia Rehabilitation Center for the Blind and Vision Impaired Celebrates Opening of New Student Dormitory 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:NIH scientists discover crucial control in long-lasting immunity 2Health News:NIH scientists discover crucial control in long-lasting immunity 3
Inquire...
Inquire...
Inquire...
Inquire...
Medicine Products: